because it is not a pharmacy medicine YET
The final decision by the delegate to make Astodrimer sodium nasal spray schedule 2 is sometime after today when final submissions close. A chance for us to say we support the interim decision and then he/she considers final submissions. In the interim decision 1 June was mentioned for potential pharmacy. SPL is not going to excite the market about interim decisions but I hope they have commenced Australian Therapeutic Goods Register ATGR application for Viraleze and with final decision the market notification is made
Why no SPL announcement on TGA decison, page-3
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
